发明申请
- 专利标题： Therapeutic Heterocyclic Compounds 507
- 专利标题（中）： 治疗性杂环化合物507
-
申请号： US11864102申请日： 2007-09-28
-
公开(公告)号： US20080076759A1公开(公告)日： 2008-03-27
- 发明人: Edward Pierson , Daniel Sohn , Markus Haeberlein , Timothy Davenport , Marc Chapdelaine , Carey Horchler , John McCauley
- 申请人： Edward Pierson , Daniel Sohn , Markus Haeberlein , Timothy Davenport , Marc Chapdelaine , Carey Horchler , John McCauley
- 申请人地址： SE Sodertalje
- 专利权人： AstraZeneca AB
- 当前专利权人： AstraZeneca AB
- 当前专利权人地址： SE Sodertalje
- 优先权： SE0103650-8 20011102; SEPCT/SE02/00068 20020115
- 主分类号： A61K31/551
- IPC分类号： A61K31/551 ; A61K31/495 ; A61K31/497 ; A61P1/00 ; A61P21/00 ; A61P5/00 ; A61P9/00 ; A61P25/06 ; A61P15/00 ; A61K31/5377 ; A61K31/541
摘要：
Provided herein is a compound having the formula (I): Wherein said compounds are useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT1B and 5HT1D antagonists.
信息查询
